IFNB1 and melanoma: For example, Liu et al. reported that IFN-β or IFN-γ treatment induces melanoma TRCs to enter dormancy via an indolamine 2,3-dioxygenase 1-kynurenine-aryl hydrocarbon receptor-p27-dependent pathway.